MAN2A2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.211800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.364400E-01
Normal-vs-Stage2
7.479300E-03
Normal-vs-Stage3
1.406450E-01
Normal-vs-Stage4
1.456610E-01
Stage1-vs-Stage2
4.080400E-01
Stage1-vs-Stage3
6.657800E-02
Stage1-vs-Stage4
3.914200E-01
Stage2-vs-Stage3
2.24919999999296E-05
Stage2-vs-Stage4
6.636200E-01
Stage3-vs-Stage4
2.143400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.893600E-02
Normal-vs-AfricanAmerican
6.716100E-02
Normal-vs-Asian
6.606200E-02
Caucasian-vs-AfricanAmerican
5.682200E-01
Caucasian-vs-Asian
4.401400E-01
AfricanAmerican-vs-Asian
9.887800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.012200E-02
Normal-vs-Female
2.258500E-02
Male-vs-Female
8.773400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.419200E-01
Normal-vs-Age(41-60Yrs)
6.004400E-02
Normal-vs-Age(61-80Yrs)
1.705650E-02
Normal-vs-Age(81-100Yrs)
2.195200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.736400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.214350E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.753000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.750370E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.014400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.231400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.858700E-03
Normal-vs-Daily Drinker
7.082100E-03
Normal-vs-Weekly Drinker
5.558500E-02
Normal-vs-Occasional Drinker
5.249600E-02
Normal-vs-Social Drinker
1.819360E-01
Non Drinker-vs-Daily Drinker
4.679400E-01
Non Drinker-vs-Weekly Drinker
3.650200E-01
Non Drinker-vs-Occasional Drinker
9.947600E-01
Non Drinker-vs-Social Drinker
2.627000E-01
Daily Drinker-vs-Weekly Drinker
1.455370E-01
Daily Drinker-vs-Occasional Drinker
5.832400E-01
Daily Drinker-vs-Social Drinker
1.301850E-01
Weekly Drinker-vs-Occasional Drinker
4.890200E-01
Weekly Drinker-vs-Social Drinker
7.755800E-01
Occasional Drinker-vs-Social Drinker
3.884600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.602600E-01
Normal-vs-Grade 2
2.118600E-01
Normal-vs-Grade 3
2.214600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.068800E-01
Grade 1-vs-Grade 3
1.155630E-01
Grade 1-vs-Grade 4
2.602600E-01
Grade 2-vs-Grade 3
9.641800E-01
Grade 2-vs-Grade 4
2.118600E-01
Grade 3-vs-Grade 4
2.214600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.368200E-01
Normal-vs-NonDiabetic
4.651800E-02
Diabetic-vs-NonDiabetic
8.743600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.377600E-02
Normal-vs-NoPancreatitis
2.948400E-02
Pancreatitis-vs-NoPancreatitis
9.321800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.907700E-02
Normal-vs-N1
9.143400E-03
N0-vs-N1
7.202000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.071800E-01
Normal-vs-TP53-NonMutant
1.893190E-01
TP53-Mutant-vs-TP53-NonMutant
6.961600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
